Cargando…
Chymase as a Novel Therapeutic Target in Acute Pancreatitis
Acute pancreatitis is still a life-threatening disease without an evidenced therapeutic agent. In this study, the effect of chymase in acute pancreatitis and the possible effect of a chymase inhibitor in acute pancreatitis were investigated. Hamsters were subcutaneously administered 3.0 g/kg of L-ar...
Autores principales: | Kuramoto, Toru, Jin, Denan, Komeda, Koji, Taniguchi, Kohei, Hirokawa, Fumitoshi, Takai, Shinji, Uchiyama, Kazuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621078/ https://www.ncbi.nlm.nih.gov/pubmed/34830195 http://dx.doi.org/10.3390/ijms222212313 |
Ejemplares similares
-
Comparison of a chymase inhibitor and hyaluronic acid/carboxymethylcellulose (Seprafilm) in a novel peritoneal adhesion model in rats
por: Ozeki, Maiko, et al.
Publicado: (2019) -
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020) -
Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2018) -
Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
por: Takai, Shinji, et al.
Publicado: (2022) -
Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
por: Terai, Kentaro, et al.
Publicado: (2020)